Home
Conditions
Paraneoplastic Syndromes, Nervous System

Clinical trial condition

Paraneoplastic Syndromes, Nervous System

Explore clinical trials studying Paraneoplastic Syndromes, Nervous System. Study availability and eligibility vary by location and protocol.

300 public trials 104 recruiting studies

Refine in advanced search Browse all conditions

Paraneoplastic Syndromes, Nervous System trial results

Not Yet Recruiting

Efficacy and Safety of Efgartigimod Sequential Therapy with Telitacicept in Generalized Myasthenia Gravis

NCT06827587

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +10 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

An Early Exploratory Clinical Study of GC012F Injection in the Treatment of Refractory Generalized Myasthenia Gravis

NCT06759948

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis (gMG), +11 more
Locations: Huashan Hospital, affiliated to Fudan University, Shanghai, Shanghai, Shanghai Municipality, China

View Trial Details

Not Yet Recruiting

Universal CAR-T Cells in Patients with Refractory Autoimmune Diseases of the Nervous System.

NCT06485232

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +30 more
Locations: Xuanwu Hospital, Capital Medical University Beijing, Beijing Municipality, China

View Trial Details

Not Yet Recruiting

Telitacicept and Low-dose Steroids in Refractory Myasthenia Gravis

NCT06723548

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +10 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Perioperative Efgartigimod for Thymoma and Myasthenia Gravis

NCT06221501

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +10 more
Locations: Not specified

View Trial Details

Completed

Relapse and Functional Outcomes in Anti-LGI1 Encephalitis

NCT07722286

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Autoimmune Encephalitis, +21 more
Locations: 2nd Affiliated Hospital, School of Medicine, Zhejiang University, China Hangzhou, Zhejiang, China

View Trial Details

Completed

Immunoadsorption Therapy in Managing NMDAR Antibodies Encephalitis

NCT03274375

Conditions: Anti-N-Methyl-D-Aspartate Receptor Encephalitis, Anti-NMDAR Encephalitis, Autoimmune Diseases, +13 more
Locations: Hôpital Necker Enfants-Malades Paris, France

View Trial Details

Completed

Disease-Modifying Treatments for Myasthenia Gravis

NCT03490539

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +11 more
Locations: Stanford University Palo Alto, California, United States

Unversity of Miami Miami, Florida, United States

Rush University Medical Center Chicago, Illinois, United States

Ochsner Clinic Foundation New Orleans, Louisiana, United States

View all 19 locations

View Trial Details

Completed

Depressive Tendency and Counseling Outcomes in Thymoma-Associated MG

NCT07649187

Conditions: Activities of Daily Living, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +25 more
Locations: Shin Kong Wu Ho-Su Memorial Hospital Taipei, Taiwan

View Trial Details

Completed

Exploring Outcomes and Characteristics of Myasthenia Gravis 2

NCT06002945

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +18 more
Locations: University of California-Irvine Irvine, California, United States

Cedars Sinai Medical Center Los Angeles, California, United States

Yale University New Haven, Connecticut, United States

George Washington University Washington D.C., District of Columbia, United States

View Trial Details

Paraneoplastic Syndromes, Nervous System

Paraneoplastic Syndromes, Nervous System trial results

Related conditions